Physicians from American Oncology Network Selected to Present at the American Society of Hematology Annual Meeting and Exposition
21 Dicembre 2023 - 2:00PM
American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s
fastest-growing networks of community oncology practices, is
pleased to announce its physicians Ruemu E. Birhiray, MD; Ralph V.
Boccia, MD, FACP; and Arvind Chaudhry, MD, PhD, were selected to
present their research results at the 65th American Society of
Hematology (ASH) Annual Meeting and Exposition in San Diego,
California, which was held on December 9 through December 12.
Each year, over 5,000 scientific abstracts undergo a meticulous
and thorough peer review process, with only a select few earning
acceptances for oral and poster presentations at the annual meeting
and exposition. The selected abstracts epitomize crucial and
innovative research in the field.
The following AON physician investigators presented their
research results during poster discussions and presentations at the
annual meeting:
- Dr. Ruemu E. Birhiray, Board-certified medical oncologist at
Hematology Oncology of Indiana, authored two reports: “Clinical
Research in the Community” and “DEI in Clinical Trials: Where Are
We Now and Where We Should Strive to be.” Dr. Birhiray also served
as moderator of the session “Setting Realistic Goals for DEI in
Hematology Trials.”
- Dr. Ralph V. Boccia, Board-certified medical oncologist at The
Center for Cancer and Blood Disorders, served as coauthor of
several reports: “Brentuximab Vedotin in Frontline Therapy of
Hodgkin Lymphoma in Patients with Significant Comorbidities
Ineligible for Standard Chemotherapy (SGN35-015 Part E),” “A Phase
1 Trial Evaluating the Addition of Lenalidomide to
Relapsed/Refractory Multiple Myeloma Patients Progressing on
Ruxolitinib and Methylprednisolone,” “Multiple Myeloma: Prospective
Therapeutic Trials: Poster III,” and “Hodgkin Lymphomas and T/NK
Cell Lymphomas: Clinical and Epidemiological: Poster
III.”
- Dr. Arvind Chaudhry, Board-certified medical oncologist at
Summit Cancer Centers, served as coauthor of one report:
“Bellwave-010: Phase 3, Open-Label, Randomized Study of
Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab in
Patients with Relapsed/Refractory Chronic Lymphocytic
Leukemia/Small Lymphocytic Lymphoma Following at Least One Prior
Therapy.”
“Having the opportunity to share and present your research at
the annual meeting is a proud accomplishment,” said Dr. Boccia, who
also serves as AON Research Committee Chairman. “As physicians, we
are on the front lines of patient care, and our research is an
extension of that commitment. This platform highlights the
alignment between medical inquiry and improved patient outcomes,
emphasizing the imperative for physicians to actively contribute to
the continuous advancements of medical knowledge. Let this moment
energize us to persist in our pursuit of medical knowledge that
contributes meaningfully to the well-being of those we
serve.”
“It is with immense pride and honor that I acknowledge the
physicians in our network who have been selected to share their
research reports with colleagues from across the nation,” said
Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their
commitment to research and the betterment of patient care is a
testament to the caliber of physicians we have at AON. I am
grateful to be a part of a network of physicians who are advancing
healthcare through research and are pushing the boundaries of
healthcare innovation to improve patient outcomes.”
According to the ASH website, the in-person and virtual annual
meeting and exposition brought together medical professionals who
specialize in hematology care for four days of immersive learning,
networking, and knowledge-sharing opportunities. It featured the
latest educational and scientific content in hematology, designed
to help attendees learn from the top minds in the field.
For more information about AON, visit
www.AONcology.com.
###
About American Oncology
Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of
physicians and seasoned healthcare leaders partnering to ensure the
long-term success and viability of community oncology and other
specialties. Founded in 2018, AON's rapidly expanding network
represents more than 220 providers practicing across 20 states. AON
pioneers innovative healthcare solutions through its physician-led
model, fostering value-based care that improves patient outcomes
while reducing costs and expanding access to quality care. AON
equips its network physicians with the tools they need to thrive
independently while providing comprehensive support, integrated
revenue-diversifying ancillary services, and practice management
expertise, enabling physicians to focus on what matters most –
providing the highest standard of care for every patient. AON is
committed to promoting health equity by addressing disparities in
cancer care and ensuring that all patients have access to the care
they need to achieve optimal health outcomes. With a focus on
innovation and collaboration, AON is shaping the future of
community oncology. Learn more at AONcology.com.
- AON Physicians Present Research Reports at Annual ASH
Conference
Caroline Hewitt
American Oncology Network
941.224.8736
Caroline.Hewitt@AONcology.com
Grafico Azioni American Oncology Network (NASDAQ:AONC)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni American Oncology Network (NASDAQ:AONC)
Storico
Da Set 2023 a Set 2024